1 Predicting Pharmacy and Other Health Care Costs Arlene S. Ash, PhD Boston University School of Medicine & DxCG, Inc. Academy Health Annual Meeting San.

Slides:



Advertisements
Similar presentations
Is There A Relationship between Hospital Encounters for Ambulatory Care Sensitive Conditions and Beneficiaries Experience and Satisfaction with Health.
Advertisements

Development and Evaluation of CMS-HCC Concurrent Risk Adjustment Models Presented by Eric Olmsted, Ph.D. Gregory Pope, M.S. John Kautter, Ph.D. RTI International.
Risk Adjustment Hierarchical Condition Categories (HCC Coding)
1 Proprietary and Confidential 1 Identification of Potentially Avoidable Emergency Department Visits Using Claims Data APHA Session : Advances in.
Overview: 1)Risk Adjustment. Program establish by Centers for Medicare and Medicaid Services [CMS] GOAL: to allocate resources to those patients who most.
Diabetes Hospital Discharge and Emergency Department Data, Montana Dorota Carpenedo, MPH Epidemiologist
Increasing Health Care Costs: the Price of Innovation? AcademyHealth Annual Research Meeting June 7, 2004 Claudia A. Steiner, MD, MPH Bernard Friedman,
Costs of chronic kidney disease USRDS 2008 Annual Data Report.
JAMES R. CHRISTINA, DPM DIRECTOR SCIENTIFIC AFFAIRS AMERICAN PODIATRIC MEDICAL ASSOCIATION FOOTCARE AND DIABETES.
Classification of Diseases
The Attention-Deficit Hyperactivity Disorder Paradox: 2. Phenotypic Variability in Prevalence and Cost of Comorbidity Larry Burd, PhD; Marilyn G. Klug,
PEBB Disease Burden Report PEBB Board of Directors August 21, 2007 Bdattach.10.
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
Hospitalizations for Severe Sepsis Among Elderly Medicare Beneficiaries William Buczko, Ph.D. Research Analyst Centers for Medicare & Medicaid Services.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Risk Adjustment and Reinsurance Regional Collaborative 1 August 9, :00 – 3:00 PM.
Medicare Risk Adjustment
Medicare Part C and the CMS- HCCs Gail Woytek, RHIA, CCS June 2, 2014.
Risk Adjustment Data For Business Insight Health Care Service Corporation September 2012.
Promoting Fair and Efficient Health Care Risk Adjustment and Predictive Modeling for Medicaid Rong Yi, PhD Senior Scientist Principal, Analytic Services.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Presented by: Total Health Care Totally There For You CODING FOR DIABETES MELLITUS 1.
Risk Adjustment Models
An Overview of NCQA’s Relative Resource Use Measures.
Modeling Risk Adjusted Capitation Rates in Regione Umbria Elaine Yuen, PhD; Daniel Z. Louis, MS; Paolo DiLoreto; Joseph S. Gonnella, MD American Public.
Virginia Health Care Conference Engaging Consumers to Purchase Value June 6, 2013.
RISK ADJUSTMENT CODING
Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments John Robst Melvin Ingber Jesse Levy Centers for Medicare & Medicaid Services.
Snapshot of IMS LifeLink Claims Database 10% Random Sample
Gaps in Drug Benefits: Impact on Utilization and Spending for Drugs Used by Medicare Beneficiaries with Serious Mental Illness Linda Simoni-Wastila, PhD.
Ryan Kelly Dr. Nicolas Shammas Christine Beuthin Jackie Carlson Marti Cox Kathy Lenaghan Dr. Ram Niwas Dr. Jon Lemke 06/18/15 ASSESSMENT OF TIME TO HOSPITAL.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
Medical Coding Chapter 4.
Analyzing NCHS Drug Data Amy B. Bernstein, Sc.D. Presented at the NCHS Board of Scientific Counselors Meeting January 28, 2005 U.S. DEPARTMENT OF HEALTH.
Influence of Comorbid Depression and Antidepressant Treatment on Mortality for Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease by SSDI-eligibility.
Title Slide Sub Title The Health Collaborative: Current Activities and Capabilities July 13, 2012 Greg Ebel, Executive Director Melissa Kennedy, Director.
Disease Burden, Utilization and Costs of Care Among Women Using Veterans Health Administration HERC Cyber Seminar May 25, 2005 Presented by Ciaran Phibbs.
Farrokh Alemi, Ph.D..  Compare effectiveness  Low dose rofecoxib (Vioxx)  High dose rofecoxib (Vioxx)  Celecoxib  Other medication.
AcademyHealth 2007 Gender Differences in Healthcare Utilization at the End-of Life Andrea Kronman, MD MSc Boston University BIRCWH Faculty Scholar Women’s.
The Developments and Applications of Disease-based Statistics in Taiwan Pi-Joen Lee Statistics Office Department of Health Oecd/Korea.
Modeling Diabetic Hospitalizations for the TennCare Population Application of Predictive Modeling for Care Management Panel AcademyHealth Annual Research.
Do Interruptions in Medicaid Coverage Increase the Risk of Preventable Hospitalizations? Andrew B. Bindman,MD Arpita Chattapadhyay PhD Glenna Auerback,
Using Clinical Information Technology to Support Better Practice Chronic Disease Care November 4, 2005 Ralph Silber, MPH, CEO Community Health Center Network.
Medicaid Analytic eXtract (MAX) Presentation to the Academy Health Annual Research Meeting San Diego, California Dave Baugh, CMS/ORDI June 8, 2004.
“Control Cost and Maintain Choice with Risk Adjustment” National Predictive Modeling Summit Michael A. Mellenthin, M.D. President Predictive Health Cost.
1 Patterns of Quality for Patients with Three Chronic Conditions Stephen M. Davidson, Ph.D. Michael Shwartz, Ph.D. Randall S.Stafford, M.D. Academy of.
Uses of NH’s Claims Database: Comprehensive Health Care Information System (CHIS) Christine Shannon Office of Medicaid Business & Policy, NH DHHS July.
Primary Care Continuity and Health Care Expenditures in a Depressed Sample of Florida Medicaid Recipients Andrea M. Lee, M.S. Robert G. Frank, Ph.D. Zoe.
Health Care Profiles in a Comparative Context Tim Miller January 19, 2007 Fourth Annual NTA Workshop.
Prescription Drug Demand for Therapeutic Substitutes: Do Copayments and Insurer Non- Price Rationing Influence Patient Utilization? Dominick Esposito AcademyHealth.
Impact of Prescription Drug Coverage on Medicare Program Expenditures: Will Part D Produce Savings in Part A and Part B? Bruce Stuart, PhD* Becky Briesacher,
Co-occurring Mental Illness and Healthcare Utilization and Expenditures Among Adults with Obesity and Chronic Physical Illness Chan Shen, MA. MS. Usha.
Introducing the New BEA Health Care Satellite Account Abe Dunn, Lindsey Rittmueller, and Bryn Whitmire SEM Conference, Paris 24 July 2015.
The Nexus of Traumatic Brain Injury and Epilepsy in Veterans from Afghanistan and Iraq Mary Jo Pugh, PhD South Texas Veterans Health Care System, San Antonio,
Mental Health and Substance Abuse Prescription Drug Spending Trends: Medicaid and Privately Insured Populations American Public Health Association Annual.
Risk Adjustment Chapter 6. 2 Medicare AAPCC: Adjusted Average Per Capita Costs Average Medicare Part A + Part B expenditures Average Medicare Part A +
HCC Coding Presentation June Risk Adjustment and Hierarchical Condition Category (HCC) Coding Mandated by the Centers for Medicare and Medicaid.
The Attention-Deficit Hyperactivity Disorder Paradox: 2
UNDERSTANDING THE MENTAL HEALTH SERVICE NEEDS OF DEPRESSED OLDER ADULTS: A STUDY OF AGE DIFFERENCES IN RECEIPT OF EVIDENCE BASED TEREATMENT FOR MAJOR.
Patterns of Allergy Immunotherapy Care Among Florida Medicaid Children with Allergic Rhinitis Presented at the 2007 APHA Annual Meeting & Exposition November.
Chapter 6: Health Expenditures for Persons with CKD
Medicare Risk Adjustment Update
Presented by Joe Nichols MD Principal – Health Data Consulting
Explore the Hierarchal Condition Category (HCC) Content in EncoderPro
Jessina C. McGregor, PhD; Miriam R. Elman, MPH; David T
COPD Hospitalizations for Elderly Medicare Beneficiaries
Chapter 7: Healthcare Expenditures for Persons with CKD
Advancing asthma care: The glass is only half full!
Presented by: John Kautter, Ph.D. Gregory Pope, M.S.
The Power of Over Reporting
Presentation transcript:

1 Predicting Pharmacy and Other Health Care Costs Arlene S. Ash, PhD Boston University School of Medicine & DxCG, Inc. Academy Health Annual Meeting San Diego, CA June 6, 2004

2 Predicting Drug and Other Costs from Administrative Data Use various “profiles” –R x –D x –Both To predict next year’s costs –Total $ –Non-pharmacy $ –Pharmacy $

3 Data “Commercial Claims and Encounters” Medstat MarketScan N ~ 1.3 million –Mean age: 33 yrs –Percent female: 51% Diagnoses: ICD-9-CM codes Pharmacy: NDC codes Costs (incl. deductibles, copays, COB)

4 ICD-9-CM codes (N = 15,000+) DxGroups (N = 781) DCG/HCC Clinical Classification 184 Hierarchical Condition Categories (HCCs) D x Clinical Classification System

5 DCG Model Structure Diagnoses drive prediction (Risk Score, or RS) –~15000 Diagnoses group  –781 Disease Groups  –184 Condition Categories (CCs) –Hierarchies imposed  184 HCCs Model –Predicts from age, sex and (hierarchical) “CC profile” –One person can have 0, 1, 2 or many (H)CCs –Risks from HCCs add to create a summary RS

6 Sample DCG/HCC Year-2 Prediction Prediction for Year 2 $ year old male $3,512 HCC16: Diabetes w neurologic or peripheral circulatory manifestation $1,903 HCC20: Type I Diabetes $266 HCC24: Other endocrine/metabolic/nutritional disorders $455 HCC43: Other musculoskeletal & connective tissue disorders _____ $6,941 FINAL PREDICTION (RS)

7 Pharmacy Model Structure 80,000+ NDC codes  155 RxGroups Hierarchies imposed –E.g., insulin dominates oral diabetic meds Relevant coefficients add to create a risk score for each person

8 NDC codes (n ~ 82,000+) RxGroups (n = 155) Aggregated Rx Categories (ARCs) (n = 17) R x Classification System

9 Sample RxGroup Year-2 Prediction $3, year old male $1,332 RxGroup 23: Anticoagulants (warfarin ) $1,314 RxGroup 42: Antianginal agents $1,538 RxGroup 116: Oral diabetic agents ______ $7,536 FINAL PREDICTION

10 Year-1 D x and R x Prevalence Diagnoses –74% have at least one valid ICD-9 code –Mean # of HCCs per person: 2.5 Pharmacy –66% have at least one prescription –Mean # of RxGroups per person: 2.5

11 Year-2 Costs Total Cost (incl., inpatient, outpatient and pharmacy) –Mean: $2,053 –CV: 386 Non-Pharmacy Cost –Mean: $1,601 –CV: 471 Pharmacy Cost –Mean: $452 –CV: 278

12 Predictive Power of Models (Validated R 2 ) Predictors Total $Non-Pharm $Pharmacy $ R x 11.6%7.1%48.2% D x 14.6%11.6%22.5% R x & D x 16.8%12.4%49.3%

13 Validated Predictive Ratios (E/O) RxRx DxDx Rx & DxRx & Dx Asthma D x (n=38,000) Asthma/COPD R x (84,000) Depression D x (49,000) Antidepressant R x (90,000) Diabetes D x (33,000) Diabetes R x (23,000)

14 Take Home Lessons Predicting next year’s cost is easiest for R x $, hardest for Non-R x $ Both kinds of data predict well –D x predicts other costs better –R x predicts R x $ much better than D x –Both together are extremely accurate The high predictabiity of R x $ from R x data bodes ill for the viability of the new Medicare drug insurance product